A new algorithm predicting imminent disease progression in advanced NSCLC patients by machine-learning integration of five serum biomarkers.

Abstract accepted for online publication in Proceedings of the ASCO Annual Meeting, June 1-5, 2018 in Chicago, Illinois. 

 

Link to Abstract